These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 7039244

  • 1. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
    Fagher B, Lundh B.
    Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244
    [Abstract] [Full Text] [Related]

  • 2. Prevention of postoperative thromboembolisms in general surgery by the combination of heparin and dihydroergotamine.
    Sándor T, László E, Magyary F, Turcsányi G, Hetényi L, Izinger E.
    Acta Chir Hung; 1986; 27(2):107-14. PubMed ID: 3529772
    [Abstract] [Full Text] [Related]

  • 3. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG, Hiltunen SJ, Suchyta M, Hull RD, Raskob GE, Pineo GF, Jensen RL, Yeates S, Kitterman N.
    Arch Intern Med; 1994 May 09; 154(9):999-1004. PubMed ID: 8179457
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H, Enomoto T, Fujiwara K, Kimura T, Kawasaki T.
    Blood Coagul Fibrinolysis; 2008 Sep 09; 19(6):585-9. PubMed ID: 18685443
    [Abstract] [Full Text] [Related]

  • 5. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M, Pattachini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, Manotti C, Dettori AG.
    Thromb Haemost; 1990 Oct 22; 64(2):222-6. PubMed ID: 2270531
    [Abstract] [Full Text] [Related]

  • 6. Different effects of heparin in males and females.
    Campbell NR, Hull RD, Brant R, Hogan DB, Pineo GF, Raskob GE.
    Clin Invest Med; 1998 Apr 22; 21(2):71-8. PubMed ID: 9562927
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD.
    Orthopedics; 1995 Jul 22; 18 Suppl():18-20. PubMed ID: 7479421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparative randomized trial of low-dose versus high-dose streptokinase in deep vein thrombosis of the thigh.
    Schulman S, Lockner D, Granqvist S, Bratt G, Paul C, Nyman D.
    Thromb Haemost; 1984 Apr 30; 51(2):261-5. PubMed ID: 6377568
    [Abstract] [Full Text] [Related]

  • 11. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL, Perkins RB, Littell RD, Krasner CN, Duska LR.
    Obstet Gynecol; 2005 May 30; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [Abstract] [Full Text] [Related]

  • 12. Comparison of heparin and streptokinase in the treatment of venous thrombosis.
    Porter JM, Seaman AJ, Common HH, Rösch J, Eidemiller LR, Calhoun AD.
    Am Surg; 1975 Sep 30; 41(9):511-19. PubMed ID: 1101755
    [Abstract] [Full Text] [Related]

  • 13. Urokinase or heparin in the management of patients with deep vein thrombosis?
    Kiil J, Carvalho A, Saksø P, Nielsen HO.
    Acta Chir Scand; 1981 Sep 30; 147(7):529-32. PubMed ID: 7048826
    [Abstract] [Full Text] [Related]

  • 14. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis.
    Tenero DM, Bell HE, Deitz PA, Bertino JS.
    Clin Pharm; 1989 Jan 30; 8(1):40-3. PubMed ID: 2912663
    [No Abstract] [Full Text] [Related]

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Jan 30; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 16. Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study.
    Arnesen H, Høiseth A, Ly B.
    Acta Med Scand; 1982 Jan 30; 211(1-2):65-8. PubMed ID: 7041523
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of distal venous thrombosis of the lower extremity with "moderated" doses of heparin].
    Rosell Pradas J, Ruiz Morales M, Tovar Martínez JL, Vara Thorbeck R.
    Angiologia; 1990 Jan 30; 42(3):100-4. PubMed ID: 2393158
    [Abstract] [Full Text] [Related]

  • 18. Heparin and its biocompatibility.
    Stiekema JC.
    Clin Nephrol; 1986 Jan 30; 26 Suppl 1():S3-8. PubMed ID: 2435441
    [Abstract] [Full Text] [Related]

  • 19. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V, Jelatancev B, Gorisek B.
    Thromb Haemost; 1994 Jul 30; 72(1):16-20. PubMed ID: 7974365
    [Abstract] [Full Text] [Related]

  • 20. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H, Marchetti O, Haeberli A, Mombelli G.
    Thromb Haemost; 1999 Oct 30; 82(4):1227-31. PubMed ID: 10544903
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.